Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Psoriasis Clinical Research Samples
Discovery Life Sciences provides the highest quality Psoriasis Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Psoriasis Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 10 of 10 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Test 2 | Test Data 2 | Test 3 | Test Data 3 | Product Details | Price | Buy | Blood Type | Co-morbidities | Consent Status Date | Current Medications | Date of Diagnosis | Diagnosis | Menopausal Status | Smoking Notes | Symptoms | ICD10 codes | Current Sign and Symptoms | Current Disease Status | Additional Notes Regarding Disease | Previous Treatment History | Comprehensive Metabolic Panel (CMP) Results | Lipid Panel Results | CT | MRI | Ultrasound | X-ray Results | Thyroid Panel Results | Additional Testing Results | ENA Panel | Complete Blood Count | Comprehensive Metabolic Panel | Additional Testing | Environmental Factors |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBS0000-AA900453766042819D1 | Psoriasis | Russia | Serum | 3.50 | 3.00 | $50.00 | 62 Y | Male | Non-Hispanic | <-70C | 28-Apr-19 | Clinical Diagnosis | Psoriatic Arthritis | $50.00 | Unknown | Chronic gastritis and Chronic prostatitis | 2019-04-28 | Ketoprofen up to 100 mg/day + Methylprednisolone 8 mg/day + Cyclosporine 125 mg/day + Omeprazole 20 mg/day since Jan-2019 | 2018-03-04 | Psoriasis | Unknown | Current smoker, 10-15 cigs per day for over 40 years | Sometimes the symptoms of coxarthritis, Some zones of psoriatic rash (elbows) 28-Apr-2019 | Sometimes the symptoms of coxarthritis, Some zones of psoriatic rash (elbows) 28-Apr-2019 | Stable | None | From 4-Mar-2018 until Dec-2018 Hydrocortisone/Salicylic acid ointment + Chloropyramine 25 mg | Glucose 5.8 mmol/L | BUN 8.4 mmol/L | Creatinine 0.089 mmol/L | Sodium 144.6 mmol/L | Potassium 4.2 mmol/L | Calcium 2.3 mmol/L | Total Protein 68 g/L | Albumin 36 g/L | Total Bilirubin 13.6 umol/L | SGOT (AST) 17.4 iu/L | SGPT (ALT) 16.2 iu/L | 16-Jun-2019 | Cholesterol 4.8 mmol/L | 27-Apr-2019 | Ultrasound - Without significant changes | X-ray - Normal | 27-Apr-2019 | Not done | ESR - 10 mm/hour | CRP 1.24 mg/L | 27-Mar-2019 | Anti-RNP - Negative | Anti-Sm - Negative | Anti-SS-A - Negative | Anti-SS-B - Negative | Sci-70 - Negative | Anti-Jo-1 - Negative | 3-Mar-2018 | WBC 7.4 x 10^9/L | RBC 4.7 x 10^12/L | Hemoglobin 158 g/L | Hematocrit 46.7% | MCV 98.1 fL | MCH 33.6 pg | MCHC 343 g/L | Neutrophils 51% | Lymphocytes 36.5% | Monocytes 8.4% | Eosinophils 2% | Basophils 0.5% | 27-Apr-2019 | |||||||||||
| BBS0000-AA900453767061719D1 | Psoriasis | Russia | Serum | 3.00 | 3.00 | $50.00 | 38 Y | Female | Non-Hispanic | <-70C | 17-Jun-19 | Clinical Diagnosis | Psoriatic Vulgaris | $50.00 | Unknown | None | 2019-06-17 | Methylprednisolone 16 mg/day + Cyclosporine 125 mg/day + Famotidine 20 mg/day since 14-Jun-2019 | 2019-05-30 | Psoriasis | Premenopausal | None | Zones of psoriatic rash | 16-Jun-2019 | Zones of psoriatic rash | 16-Jun-2019 | Newly diagnosed | Positive dynamic of treatment | From 30-May-2019 until 16-Jun-2019 Betamethasone-Salicylic acid ointment + Loratadine 7.5 mg/day + Omeprazole 20 mg/day + Methylprednisolone 24 mg/day | Glucose 5.8 mmol/L | BUN 8.4 mmol/L | Creatinine 0.089 mmol/L | Sodium 144.6 mmol/L | Potassium 4.2 mmol/L | Calcium 2.3 mmol/L | Total Protein 68 g/L | Albumin 36 g/L | Total Bilirubin 13.6 umol/L | SGOT (AST) 17.4 iu/L | SGPT (ALT) 16.2 iu/L | 16-Jun-2019 | Cholesterol 5.1 mmol/L | Triglycerides 2.4 mmol/L | HDL Cholesterol 1.23 mmol/L | Calculated LDL Chol. 2.46 mmol/L | 14-Jun-2019 | Ultrasound - Without significant changes | X-ray - Without pathology | 16-Jun-2019 | Free T3 - 5.1 pmol/L | Free T4 - 19.6 pmol/L | 10-Jun-2019 | ESR - 50 mm/hour | CRP 1.9 mg/L | 14-Jun-2019 | Anti-RNP - Negative | Anti-Sm - Negative | Anti-SS-A - Negative | Anti-SS-B - Negative | Sci-70 - Negative | Anti-Jo-1 - Negative | 3-Mar-2018 | WBC 9.2 x 10^9/L | RBC 4.0 x 10^12/L | Hemoglobin 110 g/L | Hematocrit 33.1% | MCV 83.3 fL | MCH 29 pg | MCHC 327 g/L | RDW 13.7% | Neutrophils 68.1% | Lymphocytes 23.7% | Monocytes 7.4% | Eosinophils 0.1% | Basophils 0.2% | 16-Jun-2019 | |||||||||||
| EDP0000-AA900032755031518DD | Psoriasis | Russia | K2 EDTA Plasma | 1.00 | 5.00 | Special Order. Please Inquire | 56 Y | Female | Non-Hispanic | <-70C | 15-Mar-18 | Clinical Diagnosis | Psoriatric Arthritis | CT | MRI | Ultrasound | Xray Results | MRI - Some signs of Pneumofibrosis | Ultrasound - Chronic cholecystopancreatitis 13-Mar-2018 | Current Disease Status | Responding | Special Order. Please Inquire | Unknown | Nimesulide 100 mg/twice per day + Methylprednisolone 8 mg/day + Omeprazole 20 mg/day since 6-Feb-2018 | Psoriasis | Pain in cervical spine; Some zones of psoriatic rash (elbows and knees) 15-Mar-18 | L40.5 | Cholesterol 6.05 mmol/L | Triglycerides 2.14 mmol/L | 14-Mar-2018 | WBC 7.7 x 10^9/L | RBC 4.4 x 10^12/L | Hemoglobin 122 g/L | Hematocrit 34.9% | MCV 78.1 fL | MCH 27.3 pg | MCHC 350 pg | Neutrophils 51% | Lymphocytes 42% | Monocytes 5% | Eosinophils 1% | 14-Mar-2018 | Glucose 5.18 mmol/L | Creatinine 0.078 mmol/L | Sodium 142.4 mmol/L | Potassium 4.8 mmol/L | Total Protein 63 g/L | Albumin 50 g/L | Total Bilirubin 17.6 umol/L | SGOT (AST) 17 IU/L | SGPT (ALT) 24 IU/L | 14-Mar-2018 | ANA - Negative | ESR - 50 mm/hour | RF - Negative | 14-Mar-2018 | Previous Smoker 5-10 cigs per day for over 15 years | |||||||||||||||||
| EDP0000-AA900032767042418DD | Psoriasis | Russia | K2 EDTA Plasma | 1.00 | 9.00 | Special Order. Please Inquire | 34 Y | Female | Non-Hispanic | <-70C | 24-Apr-18 | Clinical Diagnosis | Psoriatis Vulgaris | CT | MRI | Ultrasound | Xray Results | Ultrasound - Without pathology | X-ray - Normal 20-Apr-2018 | Current Disease Status | Stable | Special Order. Please Inquire | Unknown | Betamethasone-Salicylic acid ointment + Prednisolone 5 mg/day + Omeprazole 20 mg/day | Psoriasis | Positive clinical response 24-Apr-18 | L40.0 | Cholesterol 5.2 mmol/L | 23-Apr-2018 | WBC 8.2 x 10^9/L | RBC 4.7 x 10^12/L | Hemoglobin 148 g/L | Hematocrit 43.3% | MCV 91.9 fL | MCH 31.2 pg | MCHC 341 g/L | Neutrophils 63% | Lymphocytes 26% | Monocytes 8% | Eosinophils 1% | Basophils 1% | 23-Apr-2018 | Glucose 4.9 mmol/L | Creatinine 83 mmol/L | Sodium 139 mmol/L | Potassium 4.1 mmol/L | Total Protein 67.5 g/L | Total Bilirubin 8.3 umol/L | SGOT (AST) 28.2 IU/L | SGPT (ALT) 15.4 IU/L | 23-Apr-2018 | CRP 1.4 mg/L | 23-Apr-2018 | Current smoker 10-15 cigs per day for over 15 years | |||||||||||||||||
| EDP0000-AA900061627032318DD | Psoriasis | Russia | K2 EDTA Plasma | 1.00 | 10.00 | Special Order. Please Inquire | 28 Y | Female | Non-Hispanic | <-70C | 23-Mar-18 | Clinical Diagnosis | Arthropathic Psoriasis | CT | MRI | Ultrasound | Xray Results | CT - Normal 15-Jan-2018 | Ultrasound - Urolithiasis 22-Mar-2018 | X-ray - Signs of osteoporosis, Marginal defects of bone tissue 22-Mar-2018 | Current Disease Status | Progressing | Special Order. Please Inquire | Unknown | Methotrexate 20 mg/day + Folic acid 10 mg/day + Calcium and Vitamin D (1000 mg/400 iu per day + Omeprazole 20 mg/day | Psoriasis | Psoriatic rash; Pain and swelling of small joints of hands and feet; Limitation of movements in cervical and thoracic spine 23-Mar-18 | L40.5 | Cholesterol 5.6 mmol/L | 22-Mar-2018 | WBC 5.4 x 10^9/L | RBC 4.3 x 10^12/L | Hemoglobin 127 g/L | Hematocrit 35% | MCV 36.4 fL | MCH 31.5 pg | MCHC 364 g/L | Neutrophils 54% | Lymphocytes 38% | Monocytes 4% | Eosinophils 3% | Basophils 1% | 22-Mar-2018 | Glucose 5.9 mmol/L | BUN 6.3 mmol/L | Creatinine 0.068 mmol/L | EGFR: 107 mL/min/1.73 m^2 | Sodium 141 mmol/L | Potassium 3.9 mmol/L | Total Bilirubin 5.0 umol/L | SGOT (AST) 4.8 IU/L | SGPT (ALT) 17 IU/L | 22-Mar-2018 | ANA - Negative | CRP 15 mg/L | RF 6.8 iu/mL | Iron 5.6 umol/L | Vitamin B12 279 ng/mL | Ferritin 8.12 ng/mL | 22-Mar-2018 | Diet; Current smoker 5-10 cigs per day | |||||||||||||||||
| EDP0000-AA900069258040618DD | Psoriasis | Russia | K2 EDTA Plasma | 1.00 | 4.00 | Special Order. Please Inquire | 46 Y | Male | Non-Hispanic | <-70C | 06-Apr-18 | Clinical Diagnosis | Psoriatric Arthritis | CT | MRI | Ultrasound | Xray Results | CT - Pneumofibrosis 26-Dec-2017 | Ultrasound - Signs of chronic cholecystitis 5-Apr-2018 | X-ray - Sacroileitis Stage I-II 26-Dec-2017 | Current Disease Status | Flare | Special Order. Please Inquire | Unknown | Since 25-Jan-2018 Methotrexate 20 mg/day + Folic acid 5 mg/day + Diclofenac 200 mg/day + Methylprednisolone 4 mg/day + Omeprazole 20 mg/day + Pancreatin 30000 iu/day | Psoriasis | General fatigue, Psoriatic rash in zones of gluteal cleft, elbows and ears 6-Apr-18 | L40.5 | Cholesterol 5.12 mmol/L | Triglycerides 2.6 mmol/L | HDL Cholesterol 1.7 mmol/L | Calculated LDL Cholesterol 3.0 mmol/L | 5-Apr-2018 | WBC 7.4 x 10^9/L | RBC 4.9 x 10^12/L | Hemoglobin 140 g/L | Hematocrit 39% | MCH 28.4 pg | MCHC 349 g/L | Neutrophils 62% | Lymphocytes 32% | Monocytes 5% | Eosinophils 1% | | 5-Apr-2018 | Glucose 6.5 mmol/L | Creatinine 105 mmol/L | Sodium 140.8 mmol/L | Potassium 5.1 mmol/L | Total Protein 74.2 g/L | SGOT (AST) 14.8 IU/L | SGPT (ALT) 16.3 IU/L | 5-Apr-2018 | ESR - 90 mm/hour | RF - Negative | Vitamin D - 15.5 ng/L | 5-Apr-2018 | Diet; Previous smoker 15-20 cigs per day for 17-18 years | |||||||||||||||||
| EDP0000-AA900081539031418DD | Psoriasis | Russia | K2 EDTA Plasma | 1.00 | 9.00 | Special Order. Please Inquire | 29 Y | Female | Non-Hispanic | <-70C | 14-Mar-18 | Clinical Diagnosis | Psoriatis Vulgaris | CT | MRI | Ultrasound | Xray Results | Ultrasound - Biliary dyskinesia | X-ray - Normal 13-Mar-2018 | Current Disease Status | Responding | Special Order. Please Inquire | Unknown | Prednisolone 2.5 mg/day + Omeprazole 20 mg/day since 13-Mar-2018 | Psoriasis | Psoriatic rash on scalp, elbows and ears (positive effect of treatment) 14-Mar-18 | L40.0 | Cholesterol 5.1 mmol/L | 13-Mar-2018 | WBC 5.3 x 10^9/L | RBC 4.2 x 10^12/L | Hemoglobin 106 g/L | Hematocrit 34.8% | MCV 81.1 fL | MCH 25 pg | MCHC 308 g/L | Neutrophils 57.3% | Lymphocytes 32.8% | Monocytes 8.9% | Eosinophils 0.2% | Basophils 0.7% | 13-Mar-2018 | Glucose 3.9 mmol/L | BUN 4.2 mmol/L | Creatinine 0.088 mmol/L | Sodium 142 mmol/L | Potassium 4.8 mmol/L | Total Protein 60.7 g/L | Total Bilirubin 11.6 umol/L | SGOT (AST) 15.9 IU/L | SGPT (ALT) 17.2 IU/L | 13-Mar-2018 | CRP 2.4 mg/L | 13-Mar-2018 | Current smoker 5-7 cigs per day for over 10 years | |||||||||||||||||
| EDP0000-AA900081549042018DD | Psoriasis | Russia | K2 EDTA Plasma | 1.00 | 9.00 | Special Order. Please Inquire | 31 Y | Female | Non-Hispanic | <-70C | 20-Apr-18 | Clinical Diagnosis | Psoriatis Vulgaris | CT | MRI | Ultrasound | Xray Results | Ultrasound - without significant changes | X-ray - Normal 19-Apr-2018 | Current Disease Status | Newly diagnosed | Special Order. Please Inquire | Unknown | Betamethasone-Salicylic acid ointment + Loratadine 10 mg/day + Famotidine 20 mg/day | Psoriasis | Psoriatic rash on ears, umbilicus and genitalia 20-Apr-18 | L40.0 | Not done | WBC 6.5 x 10^9/L | RBC 4.4 x 10^12/L | Hemoglobin 136 g/L | Hematocrit 40.8% | MCV 92.6 fL | MCH 30.4 pg | MCHC 329 g/L | Neutrophils 40.1% | Lymphocytes 35.4% | Monocytes 8.7% | Eosinophils 11.2% | Basophils 4.5% | 19-Apr-2018 | Glucose 4.8 mmol/L | BUN 5.6 mmol/L | Creatinine 0.082 mmol/L | Sodium 141 mmol/L | Potassium 4.8 mmol/L | SGOT (AST) 29.4 IU/L | SGPT (ALT) 16.2 IU/L | 19-Apr-2018 | ANA - Negative | CRP 2.9 mg/L | 19-Apr-2018 | Current smoker 5-10 cigs per day for over 10 years | |||||||||||||||||
| EDP0000-AA900081551032218DD | Psoriasis | Russia | K2 EDTA Plasma | 1.00 | 8.00 | Special Order. Please Inquire | 46 Y | Female | Non-Hispanic | <-70C | 22-Mar-18 | Clinical Diagnosis | Psoriatis Vulgaris | CT | MRI | Ultrasound | Xray Results | Ultrasound - No significant pathological data | X-ray - Normal 20-Mar-2018 | Current Disease Status | Newly diagnosed | Special Order. Please Inquire | Unknown | Betamethasone-Salicylic acid ointment + Loratadine 10 mg/day since 20-Mar-2018 | Psoriasis | Disseminated psoriatic rash 22-Mar-18 | L40.0 | Cholesterol 5.4 mmol/L | Triglycerides 0.72 mmol/L | HDL Cholesterol 1.56 mmol/L | Calculated LDL Cholesterol 3.52 mmol/L | Risk Ratio LDL/HDL 2.5 | 20-Mar-2018 | WBC 7.2 x 10^9/L | RBC 4.15 x 10^12/L | Hemoglobin 120 g/L | Neutrophils 60.3% | Lymphocytes 24% | Monocytes 7.5% | Eosinophils 7.2% | Basophils 0.3% | 20-Mar-2018 | Glucose 4.5 mmol/L | BUN 5.5 mmol/L | Creatinine 0.068 mmol/L | Total Bilirubin 10.8 umol/L | 20-Mar-2018 | Not done | Current smoker 10-12 cigs per day for over 25 years | |||||||||||||||||
| EDP0000-AA900102937021718DD | Psoriasis | Russia | K2 EDTA Plasma | 1.00 | 10.00 | Special Order. Please Inquire | 37 Y | Male | Non-Hispanic | <-70C | 17-Feb-18 | Clinical Diagnosis | Psoriatric Arthritis | CT | MRI | Ultrasound | Xray Results | MRI - Bilateral Sacroileitis | Ultrasound - No significant data of disease | X-ray - Normal | 6-Feb-2018 | Current Disease Status | Flare | Special Order. Please Inquire | Unknown | Sandimmune - Neoral 200 mg/day + Ketoprofen 100 mg/day | Psoriasis | Moderate clinical activity of disease. Slight and moderate soreness in the feet and hands. 7-Feb-18 | L40.5 | Cholesterol 5.1 mmol/L | 7-Feb-2018 | WBC 6.2 x 10^9/L | RBC 4.9 x 10^12/L | Hemoglobin 141 g/L | Hematocrit 39% | MCV 80.5 fL | MCH 28.6 pg | MCHC 355 g/L | Neutrophils 46% | Lymphocytes 41% | Monocytes 11% | Eosinophils 1% | Basophils 1% | 7-Feb-2018 | Glucose 4.3 mmol/L | BUN 6.5 mmol/L | Creatinine 67 mmol/L | Sodium 145.2 mmol/L | Potassium 3.9 mmol/L | Calcium 1.24 mmol/L | Total Protein 73 g/L | SGOT (AST) 31 IU/L | SGPT (ALT) 27 IU/L | 7-Feb-2018 | CRP 17 mg/L | RF - Negative | 7-Feb-2018 | Diet; Current smoker 15-20 cigs per day for 20 years |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.